nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Lamivudine—hepatitis B	0.4	0.735	CbGbCtD
Topotecan—ABCB1—Lamivudine—hepatitis B	0.144	0.265	CbGbCtD
Topotecan—Hepatic pain—Telbivudine—hepatitis B	0.0813	0.18	CcSEcCtD
Topotecan—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0084	0.0186	CcSEcCtD
Topotecan—Anaphylactoid reaction—Entecavir—hepatitis B	0.00618	0.0137	CcSEcCtD
Topotecan—Sepsis—Telbivudine—hepatitis B	0.00588	0.013	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00515	0.0114	CcSEcCtD
Topotecan—Irinotecan—ALB—hepatitis B	0.0051	1	CrCbGaD
Topotecan—Neutropenia—Entecavir—hepatitis B	0.00484	0.0107	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00443	0.00981	CcSEcCtD
Topotecan—Cramp muscle—Telbivudine—hepatitis B	0.00443	0.00981	CcSEcCtD
Topotecan—Hepatobiliary disease—Entecavir—hepatitis B	0.00436	0.00967	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00434	0.00961	CcSEcCtD
Topotecan—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00425	0.00943	CcSEcCtD
Topotecan—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00401	0.00889	CcSEcCtD
Topotecan—Neutropenia—Telbivudine—hepatitis B	0.00397	0.00881	CcSEcCtD
Topotecan—Immune system disorder—Entecavir—hepatitis B	0.00374	0.00829	CcSEcCtD
Topotecan—Neuropathy peripheral—Telbivudine—hepatitis B	0.00371	0.00823	CcSEcCtD
Topotecan—Alopecia—Entecavir—hepatitis B	0.00366	0.00811	CcSEcCtD
Topotecan—Malnutrition—Entecavir—hepatitis B	0.0036	0.00799	CcSEcCtD
Topotecan—Neuropathy—Lamivudine—hepatitis B	0.00358	0.00794	CcSEcCtD
Topotecan—Hepatobiliary disease—Telbivudine—hepatitis B	0.00358	0.00794	CcSEcCtD
Topotecan—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00352	0.0078	CcSEcCtD
Topotecan—Back pain—Adefovir Dipivoxil—hepatitis B	0.0034	0.00754	CcSEcCtD
Topotecan—Hypoaesthesia—Telbivudine—hepatitis B	0.00338	0.0075	CcSEcCtD
Topotecan—Pharyngitis—Telbivudine—hepatitis B	0.00338	0.00748	CcSEcCtD
Topotecan—Sepsis—Lamivudine—hepatitis B	0.00331	0.00734	CcSEcCtD
Topotecan—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00325	0.00721	CcSEcCtD
Topotecan—Leukopenia—Entecavir—hepatitis B	0.00323	0.00715	CcSEcCtD
Topotecan—Cough—Adefovir Dipivoxil—hepatitis B	0.00307	0.0068	CcSEcCtD
Topotecan—Mediastinal disorder—Telbivudine—hepatitis B	0.00306	0.0068	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00305	0.00676	CcSEcCtD
Topotecan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00299	0.00664	CcSEcCtD
Topotecan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00299	0.00664	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00297	0.00659	CcSEcCtD
Topotecan—Malnutrition—Telbivudine—hepatitis B	0.00296	0.00656	CcSEcCtD
Topotecan—Anaphylactic shock—Entecavir—hepatitis B	0.00294	0.00652	CcSEcCtD
Topotecan—Infection—Entecavir—hepatitis B	0.00292	0.00648	CcSEcCtD
Topotecan—Nervous system disorder—Entecavir—hepatitis B	0.00288	0.0064	CcSEcCtD
Topotecan—Back pain—Telbivudine—hepatitis B	0.00286	0.00635	CcSEcCtD
Topotecan—Skin disorder—Entecavir—hepatitis B	0.00286	0.00633	CcSEcCtD
Topotecan—Muscle spasms—Telbivudine—hepatitis B	0.00285	0.00631	CcSEcCtD
Topotecan—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00281	0.00624	CcSEcCtD
Topotecan—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00281	0.00623	CcSEcCtD
Topotecan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00279	0.00618	CcSEcCtD
Topotecan—Ill-defined disorder—Telbivudine—hepatitis B	0.00275	0.00609	CcSEcCtD
Topotecan—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00274	0.00606	CcSEcCtD
Topotecan—Malaise—Telbivudine—hepatitis B	0.00267	0.00592	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00261	0.0058	CcSEcCtD
Topotecan—Dyspepsia—Entecavir—hepatitis B	0.00259	0.00574	CcSEcCtD
Topotecan—Cough—Telbivudine—hepatitis B	0.00258	0.00573	CcSEcCtD
Topotecan—Gastrointestinal disorder—Entecavir—hepatitis B	0.00254	0.00563	CcSEcCtD
Topotecan—Fatigue—Entecavir—hepatitis B	0.00254	0.00562	CcSEcCtD
Topotecan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00253	0.0056	CcSEcCtD
Topotecan—Myalgia—Telbivudine—hepatitis B	0.00252	0.00559	CcSEcCtD
Topotecan—Chest pain—Telbivudine—hepatitis B	0.00252	0.00559	CcSEcCtD
Topotecan—Arthralgia—Telbivudine—hepatitis B	0.00252	0.00559	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0025	0.00555	CcSEcCtD
Topotecan—Cramp muscle—Lamivudine—hepatitis B	0.00249	0.00553	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00249	0.00553	CcSEcCtD
Topotecan—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00249	0.00553	CcSEcCtD
Topotecan—Discomfort—Telbivudine—hepatitis B	0.00249	0.00552	CcSEcCtD
Topotecan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00248	0.00549	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00244	0.00542	CcSEcCtD
Topotecan—Gastrointestinal pain—Entecavir—hepatitis B	0.0024	0.00533	CcSEcCtD
Topotecan—Nervous system disorder—Telbivudine—hepatitis B	0.00237	0.00525	CcSEcCtD
Topotecan—Thrombocytopenia—Telbivudine—hepatitis B	0.00237	0.00525	CcSEcCtD
Topotecan—Skin disorder—Telbivudine—hepatitis B	0.00235	0.0052	CcSEcCtD
Topotecan—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00235	0.0052	CcSEcCtD
Topotecan—Abdominal pain—Entecavir—hepatitis B	0.00232	0.00516	CcSEcCtD
Topotecan—Body temperature increased—Entecavir—hepatitis B	0.00232	0.00516	CcSEcCtD
Topotecan—Pancytopenia—Lamivudine—hepatitis B	0.00227	0.00504	CcSEcCtD
Topotecan—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00227	0.00503	CcSEcCtD
Topotecan—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00227	0.00503	CcSEcCtD
Topotecan—Neutropenia—Lamivudine—hepatitis B	0.00224	0.00496	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0022	0.00488	CcSEcCtD
Topotecan—Paraesthesia—Telbivudine—hepatitis B	0.00217	0.00481	CcSEcCtD
Topotecan—Dyspepsia—Telbivudine—hepatitis B	0.00213	0.00472	CcSEcCtD
Topotecan—Asthenia—Entecavir—hepatitis B	0.00211	0.00468	CcSEcCtD
Topotecan—Neuropathy peripheral—Lamivudine—hepatitis B	0.00209	0.00464	CcSEcCtD
Topotecan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00209	0.00462	CcSEcCtD
Topotecan—Fatigue—Telbivudine—hepatitis B	0.00208	0.00462	CcSEcCtD
Topotecan—Stomatitis—Lamivudine—hepatitis B	0.00208	0.00461	CcSEcCtD
Topotecan—Pain—Telbivudine—hepatitis B	0.00207	0.00458	CcSEcCtD
Topotecan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00206	0.00456	CcSEcCtD
Topotecan—Sweating—Lamivudine—hepatitis B	0.00205	0.00454	CcSEcCtD
Topotecan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00203	0.0045	CcSEcCtD
Topotecan—Hepatobiliary disease—Lamivudine—hepatitis B	0.00202	0.00448	CcSEcCtD
Topotecan—Epistaxis—Lamivudine—hepatitis B	0.00201	0.00446	CcSEcCtD
Topotecan—Diarrhoea—Entecavir—hepatitis B	0.00201	0.00446	CcSEcCtD
Topotecan—Feeling abnormal—Telbivudine—hepatitis B	0.00199	0.00441	CcSEcCtD
Topotecan—Gastrointestinal pain—Telbivudine—hepatitis B	0.00198	0.00438	CcSEcCtD
Topotecan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00196	0.00435	CcSEcCtD
Topotecan—Dizziness—Entecavir—hepatitis B	0.00194	0.00431	CcSEcCtD
Topotecan—Rhinitis—Lamivudine—hepatitis B	0.00192	0.00426	CcSEcCtD
Topotecan—Abdominal pain—Telbivudine—hepatitis B	0.00191	0.00423	CcSEcCtD
Topotecan—Body temperature increased—Telbivudine—hepatitis B	0.00191	0.00423	CcSEcCtD
Topotecan—Hypoaesthesia—Lamivudine—hepatitis B	0.00191	0.00423	CcSEcCtD
Topotecan—Pharyngitis—Lamivudine—hepatitis B	0.0019	0.00422	CcSEcCtD
Topotecan—Vomiting—Entecavir—hepatitis B	0.00187	0.00415	CcSEcCtD
Topotecan—Rash—Entecavir—hepatitis B	0.00185	0.00411	CcSEcCtD
Topotecan—Dermatitis—Entecavir—hepatitis B	0.00185	0.00411	CcSEcCtD
Topotecan—Headache—Entecavir—hepatitis B	0.00184	0.00409	CcSEcCtD
Topotecan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00182	0.00405	CcSEcCtD
Topotecan—Rash—Adefovir Dipivoxil—hepatitis B	0.00181	0.00401	CcSEcCtD
Topotecan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00181	0.00401	CcSEcCtD
Topotecan—Headache—Adefovir Dipivoxil—hepatitis B	0.0018	0.00399	CcSEcCtD
Topotecan—Nausea—Entecavir—hepatitis B	0.00175	0.00387	CcSEcCtD
Topotecan—Asthenia—Telbivudine—hepatitis B	0.00173	0.00384	CcSEcCtD
Topotecan—Immune system disorder—Lamivudine—hepatitis B	0.00173	0.00384	CcSEcCtD
Topotecan—Mediastinal disorder—Lamivudine—hepatitis B	0.00173	0.00383	CcSEcCtD
Topotecan—Chills—Lamivudine—hepatitis B	0.00172	0.00381	CcSEcCtD
Topotecan—Pruritus—Telbivudine—hepatitis B	0.00171	0.00379	CcSEcCtD
Topotecan—Nausea—Adefovir Dipivoxil—hepatitis B	0.0017	0.00378	CcSEcCtD
Topotecan—Alopecia—Lamivudine—hepatitis B	0.00169	0.00376	CcSEcCtD
Topotecan—Malnutrition—Lamivudine—hepatitis B	0.00167	0.0037	CcSEcCtD
Topotecan—Diarrhoea—Telbivudine—hepatitis B	0.00165	0.00367	CcSEcCtD
Topotecan—Back pain—Lamivudine—hepatitis B	0.00161	0.00358	CcSEcCtD
Topotecan—Muscle spasms—Lamivudine—hepatitis B	0.0016	0.00356	CcSEcCtD
Topotecan—Dizziness—Telbivudine—hepatitis B	0.0016	0.00354	CcSEcCtD
Topotecan—Ill-defined disorder—Lamivudine—hepatitis B	0.00155	0.00343	CcSEcCtD
Topotecan—Anaemia—Lamivudine—hepatitis B	0.00154	0.00342	CcSEcCtD
Topotecan—Vomiting—Telbivudine—hepatitis B	0.00154	0.00341	CcSEcCtD
Topotecan—Angioedema—Lamivudine—hepatitis B	0.00152	0.00338	CcSEcCtD
Topotecan—Rash—Telbivudine—hepatitis B	0.00152	0.00338	CcSEcCtD
Topotecan—Dermatitis—Telbivudine—hepatitis B	0.00152	0.00337	CcSEcCtD
Topotecan—Headache—Telbivudine—hepatitis B	0.00151	0.00336	CcSEcCtD
Topotecan—Malaise—Lamivudine—hepatitis B	0.0015	0.00334	CcSEcCtD
Topotecan—Leukopenia—Lamivudine—hepatitis B	0.00149	0.00331	CcSEcCtD
Topotecan—Cough—Lamivudine—hepatitis B	0.00146	0.00323	CcSEcCtD
Topotecan—Nausea—Telbivudine—hepatitis B	0.00144	0.00318	CcSEcCtD
Topotecan—Arthralgia—Lamivudine—hepatitis B	0.00142	0.00315	CcSEcCtD
Topotecan—Myalgia—Lamivudine—hepatitis B	0.00142	0.00315	CcSEcCtD
Topotecan—Chest pain—Lamivudine—hepatitis B	0.00142	0.00315	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00141	0.00313	CcSEcCtD
Topotecan—Discomfort—Lamivudine—hepatitis B	0.0014	0.00311	CcSEcCtD
Topotecan—Anaphylactic shock—Lamivudine—hepatitis B	0.00136	0.00302	CcSEcCtD
Topotecan—Infection—Lamivudine—hepatitis B	0.00135	0.003	CcSEcCtD
Topotecan—Nervous system disorder—Lamivudine—hepatitis B	0.00134	0.00296	CcSEcCtD
Topotecan—Thrombocytopenia—Lamivudine—hepatitis B	0.00133	0.00296	CcSEcCtD
Topotecan—Skin disorder—Lamivudine—hepatitis B	0.00132	0.00293	CcSEcCtD
Topotecan—Hyperhidrosis—Lamivudine—hepatitis B	0.00132	0.00292	CcSEcCtD
Topotecan—Anorexia—Lamivudine—hepatitis B	0.0013	0.00288	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00124	0.00275	CcSEcCtD
Topotecan—Paraesthesia—Lamivudine—hepatitis B	0.00122	0.00271	CcSEcCtD
Topotecan—Dyspnoea—Lamivudine—hepatitis B	0.00121	0.00269	CcSEcCtD
Topotecan—Dyspepsia—Lamivudine—hepatitis B	0.0012	0.00266	CcSEcCtD
Topotecan—Decreased appetite—Lamivudine—hepatitis B	0.00118	0.00262	CcSEcCtD
Topotecan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00118	0.00261	CcSEcCtD
Topotecan—Fatigue—Lamivudine—hepatitis B	0.00117	0.0026	CcSEcCtD
Topotecan—Pain—Lamivudine—hepatitis B	0.00116	0.00258	CcSEcCtD
Topotecan—Constipation—Lamivudine—hepatitis B	0.00116	0.00258	CcSEcCtD
Topotecan—Feeling abnormal—Lamivudine—hepatitis B	0.00112	0.00249	CcSEcCtD
Topotecan—Gastrointestinal pain—Lamivudine—hepatitis B	0.00111	0.00247	CcSEcCtD
Topotecan—Urticaria—Lamivudine—hepatitis B	0.00108	0.0024	CcSEcCtD
Topotecan—Abdominal pain—Lamivudine—hepatitis B	0.00108	0.00239	CcSEcCtD
Topotecan—Body temperature increased—Lamivudine—hepatitis B	0.00108	0.00239	CcSEcCtD
Topotecan—Hypersensitivity—Lamivudine—hepatitis B	0.001	0.00222	CcSEcCtD
Topotecan—Asthenia—Lamivudine—hepatitis B	0.000977	0.00217	CcSEcCtD
Topotecan—Pruritus—Lamivudine—hepatitis B	0.000963	0.00214	CcSEcCtD
Topotecan—Diarrhoea—Lamivudine—hepatitis B	0.000932	0.00207	CcSEcCtD
Topotecan—Dizziness—Lamivudine—hepatitis B	0.0009	0.002	CcSEcCtD
Topotecan—Vomiting—Lamivudine—hepatitis B	0.000866	0.00192	CcSEcCtD
Topotecan—Rash—Lamivudine—hepatitis B	0.000858	0.0019	CcSEcCtD
Topotecan—Dermatitis—Lamivudine—hepatitis B	0.000858	0.0019	CcSEcCtD
Topotecan—Headache—Lamivudine—hepatitis B	0.000853	0.00189	CcSEcCtD
Topotecan—Nausea—Lamivudine—hepatitis B	0.000809	0.00179	CcSEcCtD
